Pacific Biosciences of Californ

Historical 13F Holders

Symbol
PACB
CUSIP
69404D108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 69404D108 since 12/18/2024, newest first.

Filer % of Class Filed
ARK Investment Management LLC 13G/A Amendment 7
9.6% 8/14/2026
Event 6/30/2026
Vanguard Group Inc 13G/A Amendment 4 0% 3/27/2026
Event 3/13/2026
ARK Investment Management LLC 13G/A Amendment 6
12.3% 2/3/2026
Event 12/31/2025
Madrone Capital Partners, LLC 13G/A Amendment 5
2.8% 11/14/2025
Event 9/30/2025
ARK Investment Management LLC 13G/A Amendment 5
10.3% 11/4/2025
Event 9/30/2025
Madrone Capital Partners, LLC 13G/A Amendment 4
6.8% 8/13/2025
Event 6/30/2025
Edmond De Rothschild Asset Management (France) 13G/A Amendment 1
4.5% 7/24/2025
Event 6/30/2025
Vanguard Group Inc 13G/A Amendment 3 5.5% 4/30/2025
Event 3/31/2025
BlackRock, Inc. 13G/A Amendment 11 7.7% 4/17/2025
Event 3/31/2025
Millennium Management LLC 13G/A Amendment 1
0.7% 4/9/2025
Event 3/31/2025
Millennium Management LLC 13G
6.0% 12/10/2024
Event 12/4/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 17 772 k $1.76 M
2026 Q2 232 191 M $325 M
2026 Q1 239 188 M $249 M
2025 Q4 232 201 M $374 M
2025 Q3 223 188 M $240 M
2025 Q2 223 200 M $247 M
2025 Q1 238 225 M $266 M
2024 Q4 243 260 M $475 M
2024 Q3 243 233 M $396 M
2024 Q2 252 246 M $337 M
2024 Q1 291 271 M $1.02 B
2023 Q4 301 297 M $2.92 B
2023 Q3 297 267 M $2.23 B
2023 Q2 295 257 M $3.42 B
2023 Q1 284 257 M $2.97 B
2022 Q4 256 234 M $1.92 B
2022 Q3 248 212 M $1.23 B
2022 Q2 244 225 M $1.03 B
2022 Q1 270 224 M $2.04 B
2021 Q4 286 206 M $4.21 B
2021 Q3 267 189 M $4.83 B
2021 Q2 284 173 M $6.04 B
2021 Q1 283 164 M $5.47 B
2020 Q4 237 171 M $4.44 B
2020 Q3 183 149 M $1.47 B
2020 Q2 160 109 M $375 M
2020 Q1 141 118 M $361 M
2019 Q4 151 117 M $603 M
2019 Q3 158 119 M $614 M
2019 Q2 167 125 M $757 M
2019 Q1 175 125 M $906 M
2018 Q4 172 111 M $821 M
2018 Q3 131 110 M $594 M
2018 Q2 104 93.5 M $332 M
2018 Q1 107 94.2 M $193 M
2017 Q4 115 77.9 M $206 M
2017 Q3 104 82.0 M $430 M
2017 Q2 112 79.0 M $281 M
2017 Q1 118 66.5 M $410 M
2016 Q4 128 63.5 M $241 M
2016 Q3 149 65.2 M $584 M
2016 Q2 161 61.6 M $434 M
2016 Q1 142 57.9 M $491 M
2015 Q4 132 52.3 M $687 M
2015 Q3 92 42.7 M $156 M
2015 Q2 104 42.7 M $246 M
2015 Q1 96 39.3 M $230 M
2014 Q4 104 43.6 M $342 M
2014 Q3 92 36.3 M $178 M
2014 Q2 91 37.6 M $232 M
2014 Q1 90 38.5 M $206 M